Therapy-induced tumour secretomes promote resistance and tumour progression

癌症研究 威罗菲尼 黑色素瘤 转移 生物 靶向治疗 癌细胞 抗药性 激酶 癌症 腺癌 医学 遗传学 转移性黑色素瘤 微生物学 细胞生物学
作者
Anna C. Obenauf,Yilong Zou,Andrew L. Ji,Sakari Vanharanta,Weiping Shu,Hubing Shi,Xiangju Kong,Marcus Bosenberg,Thomas Wiesner,Neal X. Rosen,Roger S. Lo,Joan Massagué
出处
期刊:Nature [Nature Portfolio]
卷期号:520 (7547): 368-372 被引量:533
标识
DOI:10.1038/nature14336
摘要

Tumour cells respond to an effective, targeted drug treatment with BRAF, ALK or EGFR kinase inhibitors by inducing a complex network of secreted signals that promote tumour growth, dissemination and metastasis of drug-resistant cancer cell clones, and increase the survival of drug-sensitive tumour cells, potentially contributing to incomplete tumour regression. Targeted kinase inhibitors such as have proved clinically effective in melanoma with BRAF mutations and in lung adenocarcinoma with EGFR mutations or ALK translocations, but drug resistance almost always follows. This study by Joan Massagué and colleagues shows that tumour cells responding to kinase inhibitors induce a complex network of secreted signals that promote tumour growth, dissemination and metastasis of drug-resistant cancer cell clones, and increase the survival of drug-sensitive tumour cells, potentially contributing to incomplete tumour regression. Drug resistance invariably limits the clinical efficacy of targeted therapy with kinase inhibitors against cancer1,2. Here we show that targeted therapy with BRAF, ALK or EGFR kinase inhibitors induces a complex network of secreted signals in drug-stressed human and mouse melanoma and human lung adenocarcinoma cells. This therapy-induced secretome stimulates the outgrowth, dissemination and metastasis of drug-resistant cancer cell clones and supports the survival of drug-sensitive cancer cells, contributing to incomplete tumour regression. The tumour-promoting secretome of melanoma cells treated with the kinase inhibitor vemurafenib is driven by downregulation of the transcription factor FRA1. In situ transcriptome analysis of drug-resistant melanoma cells responding to the regressing tumour microenvironment revealed hyperactivation of several signalling pathways, most prominently the AKT pathway. Dual inhibition of RAF and the PI(3)K/AKT/mTOR intracellular signalling pathways blunted the outgrowth of the drug-resistant cell population in BRAF mutant human melanoma, suggesting this combination therapy as a strategy against tumour relapse. Thus, therapeutic inhibition of oncogenic drivers induces vast secretome changes in drug-sensitive cancer cells, paradoxically establishing a tumour microenvironment that supports the expansion of drug-resistant clones, but is susceptible to combination therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
DJ完成签到 ,获得积分10
1秒前
慕青的应助被瓜瓜采纳,获得10
1秒前
hu完成签到 ,获得积分10
2秒前
结实的胡萝卜完成签到,获得积分10
2秒前
生化环材的生化环材完成签到,获得积分10
2秒前
乔凌云完成签到 ,获得积分10
2秒前
怡然的凌兰完成签到,获得积分10
2秒前
2秒前
平淡的惜芹完成签到,获得积分10
3秒前
CodeCraft的应助被星空采纳,获得10
3秒前
深情安青的应助被海洋蝌蚪采纳,获得10
3秒前
热情小凡完成签到,获得积分10
3秒前
jklwss完成签到,获得积分10
3秒前
swent_66完成签到,获得积分10
3秒前
3秒前
jg完成签到,获得积分10
3秒前
3秒前
zhabgyyy完成签到,获得积分10
4秒前
4秒前
4秒前
12发布了新的文献求助10
4秒前
hjabao完成签到,获得积分10
4秒前
丘比特的应助被慕念采纳,获得10
4秒前
5秒前
八倍速生活完成签到,获得积分10
5秒前
QDU的应助被吾吾采纳,获得10
5秒前
6秒前
6秒前
顺心的曲奇完成签到,获得积分10
7秒前
安静破茧完成签到,获得积分10
7秒前
便便民工完成签到,获得积分20
7秒前
8秒前
光亮向真发布了新的文献求助10
8秒前
lkk完成签到,获得积分10
8秒前
香蕉觅云的应助被失物爱采纳,获得10
8秒前
zhh发布了新的文献求助10
8秒前
冲就完了发布了新的文献求助10
8秒前
OswaldYX发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570437
关于积分的说明 21812406
捐赠科研通 7776516
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557516
邀请新用户注册赠送积分活动 2479162